Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL381669

O=C(O)C(F)(F)F.c1ccc(Oc2ccc(C3CCNCC3)cc2)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
HTR2C P28335 4/20 0.49
HTR1A P08908 5/20 0.48
SLC6A2 P23975 5/20 0.48
SLC6A4 P31645 5/20 0.48
SLC6A3 Q01959 5/20 0.48
GABRA1 P14867 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
KCNH2 Q12809 1/20 0.45
SCN3A Q9NY46 1/20 0.45
MMP3 P08254 1/20 0.44
NAMPT P43490 1/20 0.43
JAK3 P52333 1/20 0.43
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL8528751 0.87 SLC18A3 (0.69) SLC18A3SIGMAR1HTR2CNAMPTJAK3
SCHEMBL949252 0.87 SLC18A3 (0.68) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Hydrochloric Acid SCHEMBL31615878 0.85 SLC18A3 (0.66) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL942293 0.84 EPHX1 (0.52) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL6698285 0.80 HTR2C (0.54) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL2303613 0.80 HTR2C (0.78) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL6703422 0.77 HTR2C (0.51) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL21381947 0.77 HTR2C (0.50) HTR2CJAK3
Hydrochloric Acid SCHEMBL31615877 0.77 HTR2C (0.81) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2
Trifluoroacetic Acid SCHEMBL26600330 0.77 HTR2C (0.54) SLC18A3SIGMAR1HTR2CHTR1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096524-B2 Anthelmintic agents and their use INTERVET INTERNATIONAL B.V. (NL) 2015-08-04 US disclosed
EP-2408742-B1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INT BV (NL) 2014-09-03 EP disclosed
EP-2408742-A1 ANTHELMINTIC AGENTS AND THEIR USE Intervet International B.V. (NL) 2012-01-25 EP disclosed
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2011-12-29 US disclosed
WO-2010115688-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE ACHE, ABCB11, MPO SLC18A3 2405/4885SIGMAR1 4049/4885HTR2C 3378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.